News | Endovascular Aortic Repair | April 05, 2017

New Study Confirms More Unfavorable Outcomes for Women Than Men After AAA Repair

Evidence suggests Aortic Size Index (ASI) may be a better indicator for treatment for female patients and reduces gender differences in outcomes

abdominal aortic aneurysm, AAA, gender differences, women vs. men, endovascular repair, Journal of Vascular Surgery study

April 5, 2017 — Following repair of abdominal aortic aneurysms (AAA), women appear to have more unfavorable outcomes than men in terms of mortality and morbidity.

Aortic aneurysm rupture remains a significant cause for morbidity and mortality. With increasing awareness, as well as continued screening programs, the medical community can limit the impact of this vascular disease.

Current indications for surgical repair include aneurysm diameter greater than 5.5cm (in men), rapid growth, symptoms and rupture. Because women tend to be smaller in stature, repair at smaller diameters are often recommended. Women are less likely to develop AAA, but when they do, the aneurysm tends to grow faster and ruptures sooner than in men. Once treated, evidence suggests women have worse outcomes than men following procedures to repair AAA.

 As reported in an article in the April edition of the Journal of Vascular Surgery, researchers from Harvard’s Beth Israel Deaconess Medical Center and Massachusetts General Hospital, led by vascular surgeon Marc Schermerhorn, M.D., performed a study examining gender differences in AAA repair. 

Reviewing data from 6,611 patients undergoing AAA repair registered in the National Surgical Quality Improvement Program database, this group confirmed previous work suggesting higher morbidity and mortality in women following repair, even after adjusting for age, aortic diameter and other medical conditions.

A possible explanation for this difference proposed by the authors is that women have smaller baseline aortic diameters given their overall smaller body size. The researchers re-analyzed the data using Aortic Size Index (ASI) instead of aortic diameter. This index divides aortic diameter by body surface area. 

In doing so, Schermerhorn noted that “Adjusting for ASI reduces these (gender) differences, suggesting that ASI may be a better indicator threshold for AAA repair for female patients.”

Using ASI as a key component of indicator threshold may prevent unnecessary procedures, significantly reduce risk and increase the chances of a more favorable outcome.

For more information: www.jvascsurg.org


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now